Usman Salis
⬤ HIMS shares are catching attention after a brutal selloff that's kept the stock pinned near $15.6. Hims & Hers Health looks to be wrapping up a wave 2 correction after a full year of ABC decline, while the bigger-picture wave 3 target sits around $130.
⬤ The chart shows a finished rally marked as wave (1), then a drawn-out correction labeled (A), (B), and (C). Right now, price is sitting inside a Fibonacci retracement zone with key levels at 0.618 around $29.94, 0.786 near $18.01, and 0.88 close to $11.33. There's also a 1.618 extension plotted near $129.59, which lines up with that wave 3 goal. In this reading, the roughly 77% drop counts as a deep but normal wave 2 pullback, not some kind of breakdown.
⬤ HIMS stock is pressing the lower end of that retracement box after sliding from its earlier peak down into the mid-teens. This zone matters because support behavior around recent lows could signal whether a base is forming before the larger trend kicks back in. For more on nearby technical levels, check out HIMS Stock Clings to $15 Fibonacci Support After Losing Over 50% From Its Highs.
⬤ The bigger story here is that Hims & Hers Health (HIMS) appears to be shifting from a corrective phase into what could be a fresh impulsive wave, with $130 as the next major upside marker. That said, timing risk is real, and with HIMS trading near a critical Fibonacci zone while volatility often spikes around major catalysts, HIMS Earnings Watch: Hims & Hers Faces ±18% Implied Move on Report offers useful context on how the market's pricing near-term uncertainty.
Usman Salis
